Inhye Ahn
Clinical trials sponsored by Inhye Ahn, explained in plain language.
-
New treatment aims to wipe out lingering leukemia cells
Disease control Recruiting nowThis study is testing whether the drug mosunetuzumab, given alone or with other leukemia medications, can eliminate tiny amounts of remaining cancer cells in patients with chronic lymphocytic leukemia. The goal is to achieve 'undetectable minimal residual disease' - meaning no de…
Phase: PHASE1, PHASE2 • Sponsor: Inhye Ahn • Aim: Disease control
Last updated Apr 03, 2026 21:26 UTC
-
One-Year treatment trial aims to control blood cancer without lifelong drugs
Disease control Recruiting nowThis study is testing a one-year treatment plan for people newly diagnosed with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL). Participants will take the drug pirtobrutinib for six months, then add obinutuzumab for another six months, after which all trea…
Phase: PHASE2 • Sponsor: Inhye Ahn • Aim: Disease control
Last updated Mar 12, 2026 13:50 UTC